NEWS
BASF consolidates in PA 6.6 precursors
BASF and Domo Chemicals have signed an agreement giving BASF the right to take over Domo Chemicals’ 49% share of the Alsachimie joint venture, in which BASF currently holds 51%. Pending consultations, the transaction is expected to close by mid-2025. For BASF, 100% owner-
ship of Alsachimie would be a strategic step to comple- ment the company’s strong footprint at the site in Chalampé, France, its European hub for PA 6.6 precursor production. As the sole owner of Al- sachimie, BASF would be able to further strengthen its production setup and maximise backward integra- tion into key raw materials in the PA 6.6 value chain, the
group said in a statement. “As a key supplier for polyamide 6.6 precursors, it is our priority to ensure the reliable supply in Europe,” said Dr. Stephan Kothrade, member of the Board of Executive Directors of BASF. Alsachimie is located
near the French-German border and produces essential precursors for polyamides, including KA-oil, adipic acid, and hexamethylenediamine adipate (AH salt).
BASF also announced the successful startup of its new world-scale hexamethylen- ediamine (HMD) plant at the Chalampé site in June. The plant increases BASF’s annual HMD production capacity to 260,000 tonnes. In addition to starting up
the new HMD plant, the company said it was in the final stage of expanding its PA 6.6 production in Freiburg, Germany. n Ascend Performance Materials is initiating a wind down of operations at its HMD production facility in Lianyungang, China. The decision follows a compre- hensive evaluation of the facility’s long-term viability amid evolving market dynamics and regulatory landscapes, said the US-headquartered PA 6.6 company. The rest of the company’s Chinese operations, includ- ing its Suzhou compounding facility, will continue to operate as normal. �
www.basf.com �
www.ascendmaterials.com
IN BRIEF...
Krahn Chemie Benelux is expanding its long-stand- ing cooperation with specialty chemical and materials producer Vibrant Technologies, and will distribute the supplier’s pigments such as Ultrama- rines, Bismuth Vanadates, CICP, and Anticorrosives. With this agreement, Krahn Chemie encompasses the entire Vibrantz portfolio in both Benelux and Germany.
www.krahn.eu
Emirates Biotech has recently signed a supply contract with Sulzer to provide the proprietary equipment that will serve as the technological core of the PLA production facility Emirates Biotech is building in the UAE. This follows a licensing agreement signed in December 2024.
https://emiratesbiotech.com
www.sulzer.com
GreenPlast event meets expectations
The 2025 edition of GreenPlast, the Italian exhibition and conference dedicated to sustainability in the plastics industry, attracted 17,373 visitors who engaged with 200 exhibitors (of which 75% were Italian and 25% international). The organiser Promaplast said machinery manufacturers accounted for 60% of exhibitors, raw material producers 22%, and processors 18%, spread across an exhibition area of 5,500m². Feedback from exhibitors indicated a high level of satisfaction, mainly due to the quality of contacts made, said Promaplast. Visitor profiles demon- strated a growing interest in sustain- able solutions, confirming the rel- evance of the event. The conference
10 COMPOUNDING WORLD | July 2025
was organised jointly with AMI, pub- lisher of Compounding World. Once again, this edition of Green- Plast was part of The Innovation Alliance, a cross-sector event bringing together four exhibitions under a single, integrated vision. In future, each
participating exhibition will follow its own timeline, aligned with the specific requirements of its sector and carefully positioned within the international trade show calendar. �
https://greenplast.org �
www.theinnovationalliance.it
www.compoundingworld.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46
